Prognostic Nutritional Index and Neutrophil/Lymphocyte Ratio Can Serve as Independent Predictors of the Prognosis of Hepatocellular Carcinoma Patients Receiving Targeted Therapy

Table 1

Comparison of patients’ clinicopathological features between the different PNI groups.

Indicators	Low-PNI group (n = 10)	High-PNI group (n = 73)	χ^2/t
Gender			2.2221	0.1362
Male	7 (70.0)	64 (87.7)
Female	3 (30.0)	9 (12.3)
Age			0.6349	0.4256
≤56	4 (40.0)	39 (53.4)
>56	6 (60.0)	34(46.6)
History of alcoholism			9.1451	0.0025
Yes	10 (100.0)	36 (49.3)
No	0 (0)	37 (50.7)
ECOG score			0.4017	0.5262
0-1	6 (60.0)	36 (49.3)
2	4 (40.0)	37 (50.7)
Child–Pugh classification			1.7111	0.1908
A	7 (70.0)	35 (47.9)
B	3 (30.0)	38 (52.1)
BCLC stage			0.2229	0.6368
B	4 (40.0)	35 (47.9)
C	6 (60.0)	38 (52.1)
Maximum tumor diameter			0.4017	0.5262
≤5 cm	4 (40.0)	37 (50.7)
>5 cm	6 (60.0)	36 (49.3)
Number of lesions			0.2625	0.6084
Single	3 (30.0)	28 (38.4)
Multiple	7 (70.0)	45 (61.6)
Surgery			0.6349	0.4256
Yes	6 (60.0)	34 (46.6)
No	4 (40.0)	39 (53.4)

Note. PNI, prognostic nutritional index; NLR, neutrophil/lymphocyte ratio; ECOG, Eastern Cooperative Oncology Group; BCLC, Barcelona clinic liver cancer. Bold text: statistically significant.